Advertisement

Topics

New Drug Classes for Diabetes Mean New Options

06:23 EDT 30 Jun 2017 | Medscape

Dr Cyrus Desouza reviews GLP-1 receptor agonists, DPP-4 inhibitors, and SGLT2 inhibitors, offering advice on which patients may benefit from each class.
Endocrine Society

Original Article: New Drug Classes for Diabetes Mean New Options

NEXT ARTICLE

More From BioPortfolio on "New Drug Classes for Diabetes Mean New Options"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Endocrine Disorders
Endocrine disorders are grouped into two categories: hormone imbalance - when a gland produces too much or too little of an endocrine hormone development of lesions (such as nodules or tumors) in the endocrine system, which may or may not affect...